Publications

Found 8 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is H and Author is Hilibrand, Alan S  [Clear All Filters]
Journal Article
Thompson SE, Smith ZA, Hsu WK, Nassr A, Mroz TE, Fish DE, Wang JC, Fehlings MG, Tannoury CA, Tannoury T et al..  2017.  C5 Palsy After Cervical Spine Surgery: A Multicenter Retrospective Review of 59 Cases.. Global Spine J. 7(1 Suppl):64S-70S.
Hsu WK, Kannan A, Mai HT, Fehlings MG, Smith ZA, Traynelis VC, Gokaslan ZL, Hilibrand AS, Nassr A, Arnold PM et al..  2017.  Epidemiology and Outcomes of Vertebral Artery Injury in 16 582 Cervical Spine Surgery Patients: An AOSpine North America Multicenter Study.. Global Spine J. 7(1 Suppl):21S-27S.
Schroeder GD, Hilibrand AS, Arnold PM, Fish DE, Wang JC, Gum JL, Smith ZA, Hsu WK, Gokaslan ZL, Isaacs RE et al..  2017.  Epidural Hematoma Following Cervical Spine Surgery.. Global Spine J. 7(1 Suppl):120S-126S.
Daniels AH, Hart RA, Hilibrand AS, Fish DE, Wang JC, Lord EL, Buser Z, P Tortolani J, D Stroh A, Nassr A et al..  2017.  Iatrogenic Spinal Cord Injury Resulting From Cervical Spine Surgery.. Global Spine J. 7(1 Suppl):84S-90S.
Smith GA, Pace J, Corriveau M, Lee S, Mroz TE, Nassr A, Fehlings MG, Hart RA, Hilibrand AS, Arnold PM et al..  2017.  Incidence and Outcomes of Acute Implant Extrusion Following Anterior Cervical Spine Surgery.. Global Spine J. 7(1 Suppl):40S-45S.
Peterson JC, Arnold PM, Smith ZA, Hsu WK, Fehlings MG, Hart RA, Hilibrand AS, Nassr A, Rahman R'KK, Tannoury CA et al..  2017.  Misplaced Cervical Screws Requiring Reoperation.. Global Spine J. 7(1 Suppl):46S-52S.
Ailon T, Smith JS, Nassr A, Smith ZA, Hsu WK, Fehlings MG, Fish DE, Wang JC, Hilibrand AS, Mummaneni PV et al..  2017.  Rare Complications of Cervical Spine Surgery: Pseudomeningocoele.. Global Spine J. 7(1 Suppl):109S-114S.
Fehlings MG, Badhiwala JH, Ahn H, H Farhadi F, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, W Jacobs B, K Riew D et al..  2021.  Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet Neurol. 20(2):98-106.